Financhill
Back

Cardiol Therapeutics Stock Predictions

Cardiol Therapeutics Stock Forecast

  • Is Cardiol Therapeutics Stock Undervalued?
    The current Cardiol Therapeutics [CRDL] share price is $1.62. The Score for CRDL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CRDL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cardiol Therapeutics Stock Go Up Next Year?

Data Unavailable

Cardiol Therapeutics Stock Rating

Data Unavailable

Cardiol Therapeutics Stock Price History

Is CRDL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRDL is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cardiolrx.com

52-Week Data

52-Week High:
3.12
52-Week Low:
0.79

Prediction Charts

Market Cap:
132.2M
Price in USD:
1.62
Volume:
404.53K
Beta:
1.12

Technical Analysis

SMA50:
1.94
SMA100:
2.00
SMA200:
1.96
52-Wk Change:
99.19%

Stock Predictions

  • Is Cardiol Therapeutics stock public?
    Yes, Cardiol Therapeutics is a publicly traded company.
  • What is the Cardiol Therapeutics stock quote today?
    The Cardiol Therapeutics stock price is 1.62 USD today.
  • How to buy Cardiol Therapeutics stock online?
    You can buy Cardiol Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 1.90 1.96 1.97 1.90
Nov-6 1.97 1.93 1.97 1.88
Nov-7 1.90 2.07 2.24 1.90
Nov-8 2.06 1.99 2.14 1.95
Nov-11 2.02 1.96 2.07 1.90
Nov-12 1.92 1.91 1.96 1.83
Nov-13 1.98 1.91 1.98 1.87
Nov-14 1.95 1.86 1.95 1.84
Nov-15 1.84 1.82 1.87 1.72
Nov-18 1.87 1.79 1.92 1.69
Nov-19 1.80 1.65 1.80 1.61
Nov-20 1.62 1.56 1.67 1.54
Nov-21 1.59 1.58 1.60 1.49
Nov-22 1.65 1.62 1.66 1.56

Cardiol Therapeutics Earnings

Data Unavailable

Cardiol Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and an increase next year of $0.02 per share.

* Cardiol Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.